Clinical Trials on Drug Safety in Singapore
Total 10 results
-
National Cancer Centre, SingaporeTerminatedUnspecified Adult Solid Tumor, Protocol Specific | Palmar-plantar Erythrodysesthesia | Dermatologic ComplicationsSingapore
-
National Heart Centre SingaporeNational University Hospital, SingaporeUnknown
-
Clinical Nutrition Research Centre, SingaporeCompleted
-
Singapore National Eye CentreNational Medical Research Council (NMRC), Singapore; Singapore Eye Research... and other collaboratorsCompletedPterygium | Ocular Surface Disease | Chemical Injury | Stevens Johnson SyndromeSingapore
-
Clinical Nutrition Research Centre, SingaporeCompletedMarkedly Reduced Food Intake | Satiety and Food IntakeSingapore
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance)-Conditional ICDsAustralia, Germany, Switzerland, Austria, Singapore
-
Singapore General HospitalRecruitingSepsis | Bacterial Infections | Therapeutic Drug Monitoring | Hemodynamic Instability | Antimicrobial ResistanceSingapore
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
University Hospital Inselspital, BerneCompletedDrug-Eluting Stents | Coronary Thrombosis | Tomography, Optical CoherenceAustria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore